MedTrace Logo

Identification of Biomarkers in Spinocerebellar Ataxia 3

NCT03885167 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2023-11-22

No results posted yet for this study

Summary

The purpose of this study is to examine the differences in cerebral spinal fluid (CSF) and blood of patients with spinocerebellar ataxias and healthy volunteers. The goal of this project is to identify new biomarkers that are useful for characterizing spinocerebellar ataxias and identify targets for treatment or prevention of this condition.

Conditions

  • Spinocerebellar Ataxia Type 3

Interventions

OTHER

Specimen Collection

No interventions take place as part of study participation- only specimen collection occurs for both cohorts.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • University of Michigan

    lead OTHER

Principal Investigators

  • Henry Paulson, MD · University of Michigan

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-21
Primary Completion
2023-01-04
Completion
2023-01-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03885167 on ClinicalTrials.gov